A detailed history of High Tower Advisors, LLC transactions in Grifols Sa stock. As of the latest transaction made, High Tower Advisors, LLC holds 12,384 shares of GRFS stock, worth $103,406. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,384
Holding current value
$103,406
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$6.27 - $7.7 $77,647 - $95,356
12,384 New
12,384 $78,000
Q3 2018

Nov 09, 2018

SELL
$19.97 - $21.96 $1.3 Million - $1.43 Million
-65,180 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$20.16 - $24.68 $147,288 - $180,312
7,306 Added 12.62%
65,180 $1.4 Million
Q1 2018

May 15, 2018

BUY
$20.31 - $24.95 $409,348 - $502,867
20,155 Added 53.43%
57,874 $1.23 Million
Q4 2017

Feb 14, 2018

BUY
$20.99 - $23.89 $86,604 - $98,570
4,126 Added 12.28%
37,719 $864,000
Q3 2017

Nov 14, 2017

BUY
$20.07 - $21.89 $109,241 - $119,147
5,443 Added 19.34%
33,593 $737,000
Q2 2017

Aug 14, 2017

BUY
N/A
28,150
28,150 $599,000

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.67B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.